Financials

News Ideas Discussions Technicals Seasonals

0D1J fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. It focuses on the development of drug class based on the central action mechanism of Aminopeptidase A inhibition. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0D1J does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company